ClinConnect ClinConnect Logo
Search / Trial NCT06894849

Text -Based Depression Screening Among Cancer Survivors

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Mar 19, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Cancer Survivorship Depression Screening Text Message Screening Mobile Health

ClinConnect Summary

This pilot randomized controlled trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of a text message-based depression screening approach for cancer survivors. A total of 60 adult cancer survivors will be enrolled and randomly assigned to either the text message intervention or the usual care depression screening. The intervention involves sending text messages one week before scheduled oncology appointments, inviting participants to complete a depression screening using the PHQ-2, followed by the PHQ-9 for those who screen positive.

The study will assess the f...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age \> 18 years
  • diagnosis of cancer
  • upcoming appointment in an HCC or HCN oncology clinic within 14 days
  • English proficiency
  • ownership of a cellphone with SMS text capability.

Trial Officials

Evan Graboyes, MD, MPH, FACS

Principal Investigator

Medical University of South Carolina

About Medical University Of South Carolina

The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported